Pure Global
NCT06046937

Monolaurin Ointment Versus Mupirocin Ointment

A Randomized, Double-Blind Controlled Trial of Monolaurin Ointment Versus Mupirocin Ointment of Bacterial Skin Infections Among Pediatric Patients 5-18 Years Old in Community-Based Setting
Victoriano Luna Medical Center·Phase 1·ClinicalTrials.gov·drugCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Bacterial Infections
Drug/Device/Intervention
Monolaurin
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Victoriano Luna Medical Center
Location
Quezon City, Philippines
Timeline & enrollment
Phase
Phase 1
Start date
Jun 01, 2023
End date
Jul 15, 2023
Enrollment
40 participants
Primary outcome

success or failure of therapy

Summary

Skin infection remains one of the leading causes of pediatric consults especially in
 developing countries like the Philippines. This common condition has not been considered a
 significant problem that could cause alarm as public health importance. Furthermore, due to
 the consideration that skin diseases are benign, not life-threatening, and low priority.

ICD-10 classifications
Bacterial infection, unspecifiedBacterial, viral and other infectious agentsOther bacterial intestinal infectionsOther bacterial diseasesOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06046937
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06046937 through Pure Global AI's free database. This Phase 1 trial is sponsored by Victoriano Luna Medical Center and is currently Completed. The study focuses on Bacterial Infections. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.